Wells Fargo & Company Harvard Bioscience Inc Transaction History

Wells Fargo & Company

  • $407 Billion
  • Q2 2024

A detailed history of Wells Fargo & Company transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Wells Fargo & Company holds 17,830 shares of HBIO stock, worth $42,613. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,830
Previous 13,299 34.07%
Holding current value
$42,613
Previous $56,000 10.71%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$2.77 - $4.63 $12,550 - $20,978
4,531 Added 34.07%
17,830 $50,000
Q1 2024

May 10, 2024
BUY
$4.02 - $5.39 $6,524 - $8,747
1,623 Added 13.9%
13,299 $56,000
Q4 2023

Feb 09, 2024
BUY
$4.0 - $5.49 $9,936 - $13,637
2,484 Added 27.02%
11,676 $62,000
Q3 2023

Nov 13, 2023
SELL
$4.0 - $5.82 $29,120 - $42,369
-7,280 Reduced 44.2%
9,192 $39,000
Q2 2023

Aug 15, 2023
BUY
$4.19 - $6.16 $67,957 - $99,909
16,219 Added 6410.67%
16,472 $90,000
Q1 2023

May 12, 2023
SELL
$2.45 - $4.22 $12,242 - $21,087
-4,997 Reduced 95.18%
253 $1,000
Q4 2022

Feb 13, 2023
BUY
$2.12 - $2.86 $10,614 - $14,320
5,007 Added 2060.49%
5,250 $14,000
Q3 2022

Nov 14, 2022
SELL
$2.33 - $3.92 $6 - $11
-3 Reduced 1.22%
243 $1,000
Q2 2022

Aug 12, 2022
SELL
$3.28 - $6.42 $143,093 - $280,078
-43,626 Reduced 99.44%
246 $1,000
Q1 2022

May 16, 2022
SELL
$5.16 - $7.14 $670,903 - $928,342
-130,020 Reduced 74.77%
43,872 $272,000
Q4 2021

Feb 14, 2022
SELL
$6.37 - $8.18 $1.58 Million - $2.03 Million
-248,607 Reduced 58.84%
173,892 $1.23 Million
Q3 2021

Nov 15, 2021
SELL
$6.98 - $8.47 $4,795 - $5,818
-687 Reduced 0.16%
422,499 $2.95 Million
Q2 2021

Aug 16, 2021
BUY
$5.44 - $8.4 $958,816 - $1.48 Million
176,253 Added 71.38%
423,186 $3.53 Million
Q1 2021

May 13, 2021
BUY
$3.91 - $6.99 $740,037 - $1.32 Million
189,268 Added 328.22%
246,933 $1.35 Million
Q4 2020

Feb 09, 2021
SELL
$3.0 - $4.5 $137,760 - $206,640
-45,920 Reduced 44.33%
57,665 $247,000
Q3 2020

Nov 05, 2020
BUY
$2.75 - $4.2 $102,839 - $157,063
37,396 Added 56.5%
103,585 $312,000
Q2 2020

Aug 13, 2020
BUY
$2.12 - $3.14 $33,303 - $49,326
15,709 Added 31.12%
66,189 $206,000
Q1 2020

May 14, 2020
BUY
$1.42 - $3.29 $71,681 - $166,079
50,480 New
50,480 $111,000

Others Institutions Holding HBIO

# of Institutions
106
Shares Held
32.2M
Call Options Held
1.2K
Put Options Held
1.2K
View Full List

About HARVARD BIOSCIENCE INC

HBIO Quotes by TradingView
  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $99.5M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email